Basket | Login

 
 
 
 

Phase II trials

Clinical Trials Watch

This section contains information about clinical trials that are:

  • Currently recruiting participants
  • Conducted at least in one European country
  • In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)

How many Phase II trials are reported in the CTW?

The CTW reports currently 8 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:

Study

Study sponsor

Name of the drug

Condition

ACI-35-1802

AC Immune

ACI-35.030 or JACI-35.054

Early Alzheimer's disease

AUTONOMY

Janssen

JNJ-63733657

Early Alzheimer's disease

Brainshuttle AD

Hoffmann-La Roche

RO7126209

Prodromal or mild to moderate Alzheimer's disease

DESPIAD

University College London

CPHPC

Mild Alzheimer's disease

INFRONT2

Alector

AL001

Frontotemporal dementia

INVOKE-2

Alector

AL002

Early Alzheimer's disease 

TRAILBLAZER-ALZ 2

Eli Lilly

Donanemab

Early Alzheimer's disease

VIVIAD

Vivoryon Therapeutics AG

PQ912

Mild cognitive impairment and mild dementia due to Alzheimer 's Disease

 

 
 

Last Updated: Monday 18 October 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options